Global Insulin Patch Pumps Market Set For 10.3% Growth, Reaching $2.16 Billion By 2028

November 28, 2024 12:30 AM PST | By EIN Presswire
 Global Insulin Patch Pumps Market Set For 10.3% Growth, Reaching $2.16 Billion By 2028
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, November 28, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!

What is the Expected Market Size and Growth Rate for Insulin Patch Pumps in 2024?

The insulin patch pumps market size has seen significant expansion in recent years. It is predicted to grow from a value of $1.32 billion in 2023 to $1.46 billion in 2024, showcasing a compound annual growth rate CAGR of 11.0%. The growth during this period can be attributed to factors such as the increasing prevalence of diabetes, patient preference for non-invasive delivery mechanisms, a growing geriatric population, heightened safety concerns, and advancements in miniaturization and improved form factors of insulin patch pumps.

What Does the Future Hold for the Insulin Patch Pumps Market?

Projecting beyond the current market kinetics, the insulin patch pumps market is set to witness a rapid expansion. Forecasts indicate growth to $2.16 billion by 2028, maintaining a compound annual growth rate CAGR of 10.3%. Future growth will likely be fueled by an increasing acceptance of telehealth, a rise in pediatric diabetes cases, heightened awareness of diabetes, environmental and sustainability considerations, and burgeoning healthcare initiatives.

The forecast period could also see trends such as quantum computing design tools, the increasing integration of artificial intelligence and machine learning, the adoption of digital twin simulations, advancements in custom ic design tools, and growth in high-level synthesis tools, which could significantly impact market dynamics.

See a detailed sample report here: https://www.thebusinessresearchcompany.com/sample.aspx?id=6486&type=smp

What Are the Primary Growth Drivers for the Insulin Patch Pumps Market?

The alarming rise in diabetes prevalence worldwide is anticipated to significantly propel the growth of the insulin patch pumps market. Diabetes, a major global health concern, results from various lifestyle and dietary factors. Insulin patch pumps greatly simplify the process of insulin delivery, providing a more convenient alternative to traditional insulin injections.

Considering data from the International Diabetes Federation, around 537 million people aged between 20 to 79 years had diabetes in 2021, and these figures are estimated to cross 643 million by 2030. The diabetes-led mortality rate is also strikingly high, with around 6.7 million fatalities reported in 2021. These statistics underline the growing need for insulin patch pumps, and will likely continue to stimulate market growth.

Don't miss the comprehensive report: https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report

Which Key Players Are Directing the Course of the Insulin Patch Pumps Market?

The insulin patch pumps market landscape comprises several important industry players. High-profile entities include Cellnovo Group SA, Insulet Corporation, Medtronic PLC, Tandem Diabetes Care Inc., Hoffmann-La-Roche AG, and others. With these major players continually exploring innovative approaches, the industry's future appears bright.

What Influence Is Technological Advancement Having on the Insulin Patch Pumps Market?

Emerging trends suggest that the integration of advanced technologies in insulin patch pumps is becoming increasingly popular. Advanced functions such as smartphone integration and the automation of insulin delivery have begun to be introduced in insulin patch pump designs. Simultaneously, advances in glucose monitoring devices are enabling these devices to automate insulin delivery further, reducing the need for manual intervention.

For example, in January 2022, Insulet Corporation, a US-based medical device innovator, received FDA acceptance for its Omnipod 5 automated insulin delivery system. This system, intended for patients with type 1 diabetes aged 6 years and older, is the only automated insulin delivery system that is tubeless and can be controlled through a compatible smartphone. By eliminating the need for multiple daily injections and fingersticks, this product signifies a significant step forward in diabetes management.

How Is the Insulin Patch Pumps Market Categorized?

The market report segments the insulin patch pumps market as follows:

1 By Type: Traditional Insulin Pumps, Smart Insulin Pump, Disposable Insulin Pumps
2 By Mode: Basal, Bolus
3 By Pump Type: Tethered Pump, Patch Pump
4 By Application: Type 1 Diabetes, Type 2 Diabetes
5 By End-User: Hospital, Clinics, Laboratories, Other End-Users

This segmentation gives a clear picture of the various areas that constitute the insulin patch pumps market.

What Are the Geographical Dynamics of the Insulin Patch Pumps Market?

Looking at the regional dynamics, North America led the insulin patch pumps market in 2023. However, the fastest-growing region in the forecast period is expected to be Asia-Pacific. The markets covered in this report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse more similar reports-
Insulin Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report
Smart Insulin Pens Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report


Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next